Fan Jianxun, Vice President and CFO of Baida Pharmaceuticals: Promote industrial upgrading through technological innovation and ecological construction.

Vice President and CFO Fan Jianxun of Beida Pharmaceuticals stated at the conference that Beida Pharmaceuticals, as a leading company in the industry developed from technological innovation enterprises, is promoting industry development through technological innovation and ecological construction, and integrating financial capital with industrial capital by creating a medical innovation ecosystem. The innovative ecosystem is centered around Beida Pharmaceuticals, with industrial capital and the Beida Dream Factory as its two wings, focusing on the layout of the pharmaceutical industry, cutting-edge science, and clinical demand planning. The ecosystem has gathered hundreds of projects, more than 300 talents, and an industrial fund of about 3 billion RMB. The investment in the field of biomedicine has produced significant results, with three companies already listed on the stock market. In the coming years, it is expected that 8-10 new drug projects will enter phase III clinical trials or new drug approval within the ecosystem, covering areas such as tumors, stem cells, and recombinant albumin, which are globally leading projects. In the future, Beida's ecosystem will leverage the advantages of the complete chain from research and development to commercialization of Beida Pharmaceuticals, enriching the innovative ecosystem with various modes such as strategic investment, synergy, extension, and incubation, to support the development of the pharmaceutical industry.